EUVIMEDEUVIMED entdecken
Crossref

Novel Quinazolinone Derivatives: Potential Synthetic Analogs for the Treatment of Glaucoma, Alzheimer's Disease and Diabetes Mellitus

Feyzi Sinan Tokalı iD, Parham Taslimi iD, Burak Tuzun iD, Ahmet Karakuş iD, Nastaran Sadeghian iD, İlhami Gulçin iD

Chemistry & Biodiversity · 2023

DOI: 10.1002/cbdv.202301134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Feyzi Sinan Tokalı und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, 36100, Turkiye. Hauptthemen laut MEDLINE: Alzheimer Disease, Quinazolinones, Cholinesterase Inhibitors, Glaucoma. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Scientific Research Projects Commission of Bartın University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quinazolinones, which represent an important part of nitrogen‐containing six‐membered heterocyclic compounds, are frequently used in drug design due to their wide biological activity properties. Therefore, the novel quinazolinones were synthesized from the reaction of acylated derivatives of 4‐hydroxy benzaldehyde with 3‐amino‐2‐alkylquinazolin‐4( 3H )‐ones with good yields (85–94 %) and their structures were characterized using Fourier‐transform Infrared (FT‐IR), Nuclear Magnetic Resonance ( 1 H‐NMR, 13 C‐NMR), and High‐Resolution Mass Spectroscopy (HR‐MS). As the application of the synthesized compounds, their inhibition properties of the synthesized compounds on α‐Glucosidase (α‐Glu), Acetylcholinesterase (AChE), Butyrylcholinesterase (BChE), and Carbonic anhydrase I–II (hCA I–II) metabolic enzymes were investigated. All compounds showed inhibition at nanomolar level with the K i values in the range of 12.73±1.26–93.42±9.44 nM for AChE, 8.48±0.92–25.84±2.59 nM for BChE, 66.17±5.16–818.06±44.41 for α‐Glu, 2.56±0.26–88.23±9.72 nM for hCA I, and 1.68±0.14–85.43±7.41 nM for hCA II. Molecular docking study was performed to understand the interactions of the most potent compounds with corresponding enzymes. Also, absorption, distribution, metabolism, excretion, and toxicity (ADME/T) properties of the compounds were investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseQuinazolinonesCholinesterase InhibitorsGlaucomaDiabetes MellitusAcetylcholinesteraseButyrylcholinesteraseHumansMolecular Docking SimulationStructure-Activity Relationshipalpha-GlucosidasesMolecular StructureDose-Response Relationship, DrugCarbonic Anhydrase InhibitorsGlycoside Hydrolase InhibitorsAnimals

Stichwörter der Autor:innen

ADME/Tcholinesterasesdiabetesmolecular dockingquinazolin-4(3H)-one

Substanzen

AcetylcholinesteraseButyrylcholinesteraseQuinazolinonesCholinesterase Inhibitorsalpha-GlucosidasesCarbonic Anhydrase InhibitorsGlycoside Hydrolase Inhibitors

Autor:innen und Institutionen

  • Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, 36100, Turkiye.
  • Department of Biotechnology, Faculty of Science, Bartin University, Bartin, 74100, Turkiye.
  • Departmentof Plant and Animal Production, Sivas Technical Sciences Vocational School, Sivas Cumhuriyet University, 58140, Sivas, Turkiye.
  • Department of Chemistry, Faculty of Sciences, Atatürk University, 25240-, Erzurum, Turkiye.

ORCID-Profile: Feyzi Sinan Tokalı, Parham Taslimi, Burak Tuzun, Ahmet Karakuş, Nastaran Sadeghian, İlhami Gulçin

Förderung

  • Scientific Research Projects Commission of Bartın University

Zitieren

APA

Tokalı, F. S., Taslimi, P., Tuzun, B., Karakuş, A., Sadeghian, N., & Gulçin, İ. (2023). Novel Quinazolinone Derivatives: Potential Synthetic Analogs for the Treatment of Glaucoma, Alzheimer's Disease and Diabetes Mellitus. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301134

Vancouver

Tokalı FS, Taslimi P, Tuzun B, Karakuş A, Sadeghian N, Gulçin İ. Novel Quinazolinone Derivatives: Potential Synthetic Analogs for the Treatment of Glaucoma, Alzheimer's Disease and Diabetes Mellitus. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202301134

BibTeX
@article{Tokal2023,
  author = {Tokalı, Feyzi Sinan and Taslimi, Parham and Tuzun, Burak and Karakuş, Ahmet and Sadeghian, Nastaran and Gulçin, İlhami},
  title = {Novel Quinazolinone Derivatives: Potential Synthetic Analogs for the Treatment of Glaucoma, Alzheimer's Disease and Diabetes Mellitus},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  doi = {10.1002/cbdv.202301134}
}
Kostenlos starten →